DRalpha1-hMOG-35-55 (Virogenomics Biodevelopment)

N/A

Report date: 2025/03/18 18:21:38

Base Information

Drug NameDRalpha1-hMOG-35-55 (Virogenomics Biodevelopment)
Drug Alias NameDRhQDRalpha1-hMOG-35-55
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionHLA-DR antigens-associated invariant chain inhibitorsMacrophage migration inhibitory factor inhibitors
TargetsHLA-DR antigens-associated invariant chainMacrophage migration inhibitory factor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVirogenomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVirogenomics Inc
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A